ATE454906T1 - Feste zusammensetzung mit einem protonenpumpenhemmer - Google Patents

Feste zusammensetzung mit einem protonenpumpenhemmer

Info

Publication number
ATE454906T1
ATE454906T1 AT04749149T AT04749149T ATE454906T1 AT E454906 T1 ATE454906 T1 AT E454906T1 AT 04749149 T AT04749149 T AT 04749149T AT 04749149 T AT04749149 T AT 04749149T AT E454906 T1 ATE454906 T1 AT E454906T1
Authority
AT
Austria
Prior art keywords
proton pump
pump inhibitor
solid composition
pellets
composition containing
Prior art date
Application number
AT04749149T
Other languages
English (en)
Inventor
Eva Blychert
Marjo Janssen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE454906T1 publication Critical patent/ATE454906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04749149T 2003-07-11 2004-07-08 Feste zusammensetzung mit einem protonenpumpenhemmer ATE454906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48679503P 2003-07-11 2003-07-11
PCT/SE2004/001113 WO2005004921A1 (en) 2003-07-11 2004-07-08 Solid composition comprising a proton pump inhibitor

Publications (1)

Publication Number Publication Date
ATE454906T1 true ATE454906T1 (de) 2010-01-15

Family

ID=34062141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04749149T ATE454906T1 (de) 2003-07-11 2004-07-08 Feste zusammensetzung mit einem protonenpumpenhemmer

Country Status (7)

Country Link
US (1) US20070053981A1 (de)
EP (1) EP1646404B1 (de)
JP (1) JP2007522086A (de)
AT (1) ATE454906T1 (de)
DE (1) DE602004025113D1 (de)
ES (1) ES2338009T3 (de)
WO (1) WO2005004921A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
EP1755566A2 (de) * 2004-06-15 2007-02-28 Teva Pharmaceutical Industries Ltd Stabile pharmazeutische formulierungen von benzimidazolverbindungen
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
ITMI20062290A1 (it) * 2006-11-28 2008-05-29 Monteres S R L Compresse stabili allo stoccaggio a base di derivati del benzimidazolo rivestite con film gastro-resistente
JP2012072061A (ja) * 2009-01-29 2012-04-12 Eisai R & D Management Co Ltd 新規組成物
US20110066141A1 (en) * 2009-09-11 2011-03-17 Cook Incorporated Implantable medical device having an anti-gastric distress agent
US20140179637A1 (en) 2012-12-21 2014-06-26 The Research Foundation For The State University Of New York Methods and compounds to inhibit enveloped virus release
GB2535130B (en) * 2014-09-29 2020-09-02 Veriton Pharma Ltd A Suspension
EP3277267B1 (de) * 2015-03-31 2021-01-06 Laboratorios Bagó S.A. Magensaftresistent umhüllte pellets enthaltend einen protonenhemmer
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CN105125507B (zh) * 2015-08-19 2018-03-06 德州德药制药有限公司 一种埃索美拉唑钠注射用冻干粉组合物及其制备方法
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
AU2017339247B2 (en) * 2016-10-06 2020-07-23 Jubilant Generics Limited Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof
EP3720844A4 (de) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Arzneimittelzusammensetzungen
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
KR102006777B1 (ko) * 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
WO2020040438A1 (ko) 2018-08-23 2020-02-27 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 우수한 방출특성을 갖는 약제학적 제제
US11666562B2 (en) 2020-04-02 2023-06-06 Northwestern University Ilaprazole for inhibiting the release of enveloped viruses from cells
CA3249196A1 (en) * 2022-01-20 2023-07-27 Bionxt Solutions Inc. CHEMICAL COMPOSITION FOR THE ADMINISTRATION OF AN ENTERIC MEDICINE
KR102553713B1 (ko) * 2022-11-18 2023-07-10 고덕상 미네랄 촉매제를 이용한 양식어류사료 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
DK0662320T3 (da) * 1991-08-30 2001-09-24 Showa Pharm Chem Ind Tør gelsammensætning
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US5869118A (en) * 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
HK1040191A1 (zh) * 1998-07-31 2002-05-31 大塚制药株式会社 具有改良味道的药物组合物
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation

Also Published As

Publication number Publication date
EP1646404B1 (de) 2010-01-13
JP2007522086A (ja) 2007-08-09
EP1646404A1 (de) 2006-04-19
WO2005004921A1 (en) 2005-01-20
ES2338009T3 (es) 2010-05-03
US20070053981A1 (en) 2007-03-08
DE602004025113D1 (de) 2010-03-04

Similar Documents

Publication Publication Date Title
DE602004025113D1 (de) Feste zusammensetzung mit einem protonenpumpenhemmer
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
EA200400777A1 (ru) Фармацевтические композиции соединения платины
FI4303583T3 (fi) Csf1r-estäjiä käytettäviksi tenosynoviaalisen jättisolukasvaimien hoidossa
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
JP2019131596A5 (de)
EP1529527A3 (de) Valproinsäure zur Kombinationsbehandlung von Krebs bei Menschen und zur Behandlung von Tumormetastasen und minimaler Resterkrankung
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
JP2013209416A (ja) 胃の逆流抵抗性投薬形態
KR880008803A (ko) 핵을 갖는 구형 과립 및 그의 제조방법
KR870003778A (ko) 신규 약제의 제조방법
JP2006206613A (ja) 粘膜炎の処置および予防のための方法および組成物
JP2006516272A5 (de)
RU2009101324A (ru) Композиции и способы лечения воспаления слизистой оболочки
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
ATE466008T1 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
CA2502731A1 (en) Sustained release composition for oral administration of drugs
EA200600377A1 (ru) Новая композиция
RU2005105302A (ru) Композиция бицифадина
CO5690532A2 (es) Formas de dosificacion farmaceutica de liberacion extendida
WO2003039439A3 (de) Deuterierte pyrazolopyrimidinone sowie diese verbindungen enthaltende arzneimittel
TWI482632B (zh) 醫藥用載體及使用該載體的藥物結構
JP2012041314A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties